Extended access to methamphetamine self-administration affects sensorimotor gating in rats

Behavioural Brain Research

Volumn 217, Issue 2, 2011, Pages 386-390

  Hadamitzky, Martin ^a,b   Markou, Athina ^a   Kuczenski, Ronald ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Escalation; Methamphetamine; Self administration; Sensorimotor gating

Indexed keywords

METHAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORY GATING; STARTLE REFLEX; SUBSTANCE ABUSE;

ACOUSTIC STIMULATION; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHAMPHETAMINE; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SENSORY GATING; STARTLE REACTION; TIME FACTORS;

EID: 78650414337     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.11.009     Document Type: Article

References (41)

1. Angrist B. Amphetamine psychosis: clinical variations of the syndrome. Amphetamine and its analogues 1994, 387-414. Academic Press, San Diego. A.K. Cho, D.S. Segal (Eds.).
2. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001, 156:234-258.
3. Brunell S.C., Spear L.P. Effects of acute ethanol or amphetamine administration on the acoustic startle response and prepulse inhibition in adolescent and adult rats. Psychopharmacology 2006, 186:579-586.
4. Cadenhead K.S., Light G.A., Geyer M.A., McDowell J.E., Braff D.L. Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype?. Am. J. Psychiatry 2002, 159:869-871.
5. Caine B., Lintz R., Koob G.F. Intravenous drug-self-administration techniques in animals. Behavioural neuroscience: a practical approach 1993, 117-143. Oxford University Press. A. Sahgal (Ed.).
6. Chang L., Alicata D., Ernst T., Volkow N Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 2007, 102(Suppl. 1):16-32.
7. Cilia J., Reavill C., Hagan J.J., Jones D.N.C. Long-term evaluation of isolation-reared prepulse inhibition deficits in rats. Psychopharmacology 2001, 156:327-337.
8. Cilia J., Hatcher P., Reavill C., Jones D.N. (+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics. J Psychopharmacol 2007, 21:302-311.
9. Davidson C., Gow A.J., Lee T.H., Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Rev 2001, 36:1-22.
10. Druhan J.P., Geyer M.A., Valentino R.J. Lack of sensitization to the effects of d-amphetamine and apomorphine on sensorimotor gating in rats. Psychopharmacology 1998, 135:296-304.
11. Featherstone R.E., Kapur S., Fletcher P.J. The amphetamine-induced sensitized state as a model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1556-1571.
12. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001, 156:117-154.
13. Hemby S.E., Co C., Koves T.R., Smith J.E., Dworkin S.I. Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology 1997, 133:7-16.
14. Hutchison K.E., Swift R. Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology 1999, 143:394-400.
15. Jacobs E.H., Smit A.B., De Vries T.J., Schoffelmeer A.N. Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol Sci 2003, 24:566-573.
16. Kitamura O., Wee S., Specio S.E., Koob G.F., Pulvirenti L. Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology 2006, 186:48-53.
17. Kiyatkin E.A., Brown P.L. Brain temperature fluctuations during passive vs. active cocaine administration: clues for understanding the pharmacological determination of drug-taking behavior. Brain Res 2004, 1005:101-116.
18. Koch M. The neurobiology of startle. Prog Neurobiol 1999, 59:107-128.
19. Light G.A., Braff D.L. Stability of mismatch negativity deficits and their relationship to functional impairments in chronic schizophrenia. Am J Psychiatry 2005, 162:1741-1743.
20. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 1998, 94:507-514.
21. Melega W.P., Williams A.E., Schmitz D.A., DiStefano E.W., Cho A.K. Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J Pharmacol Exp Ther 1995, 274:90-96.
22. Meredith C.W., Jaffe C., Ang-Lee K., Saxon A.J. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005, 13:141-154.
23. Nordahl T.E., Salo R., Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci 2003, 15:317-325.
24. Riviere G.J., Byrnes K.A., Gentry W.B., Owens S.M. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat. J Pharmacol Exp Ther 1999, 291:1220-1226.
25. Rogers J.L., De Santis S., See R.E. Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology 2008, 199:615-624.
26. Schwendt M., Rocha A., See R.E., Pacchioni A.M., McGinty J.F., Kalivas P.W. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 2009, 331:555-562.
27. Segal D.S., Schuckit M.A. Animal models of stimulant-induced psychosis. Stimulants: neurochemical, behavioral, and clinical perspectives 1983, 131-167. Raven Press, New York. I. Creese (Ed.).
28. Simon S.L., Richardson K., Dacey J., Glynn S., Domier C.P., Rawson R.A., et al. A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 2002, 21:35-44.
29. Stefanski R., Ladenheim B., Lee S.H., Cadet J.L., Goldberg S.R. Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol 1999, 371:123-135.
30. Stuber G.D., Roitman M.F., Phillips P.E.M., Carelli R.M., Wightman R.M. Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration. Neuropsychopharmacology 2005, 30:853-863.
31. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 1998, 24:285-301.
32. Swerdlow N.R., Benhow C.H., Zisook S., Geyer M.A., Braff D.L. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 1993, 33:298-301.
33. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 1994, 51:139-154.
34. Swerdlow N.R., Paulsen J., Braff D.L., Butters N., Geyer M.A., Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 1995, 58:192-200.
35. Swerdlow N.R., Braff D.L., Geyer M.A. Animal models of deficient sensorimotor gating: what we know, what we think to know, and what we hope to know soon. Behav Pharmacol 2000, 11:185-204.
36. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 2001, 156:194-215.
37. Swerdlow N.R., Shoemaker J.M., Bongiovanni M.J., Neary A.C., Tochen L.S., Saint Marie R.L. Reduced startle gating after D1 blockade: effects of concurrent D2 blockade. Pharmacol Biochem Behav 2005, 82:293-299.
38. Tenn C.C., Fletcher P.J., Kapur S. Amphetamine-sensitized animals show a sensorimotor gating and neurochemical abnormality similar to that of schizophrenia. Schizophr Res 2003, 64:103-114.
39. Tenn C.C., Kapur S., Fletcher P.J. Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition. Psychopharmacology 2005, 180:366-376.
40. Volz T.J., Fleckenstein A.E., Hanson G.R. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. Addiction 2007, 102(Suppl. 1):44-48.
41. Winsauer P.J., Moerschbaecher J.M., Molina P.E., Roussell A.M. Contingent and concontingent cocaine administration in rhesus monkeys: a comparison of the effects on the acquisition and performance of response sequences. Behav Pharmacol 2003, 14:295-306.